Stockscreener 앱 받기
2.606
0.91%
-0.024
시간 외 거래:
2.61
0.004
+0.15%
InspireMD Inc. 주식(NSPR)의 최신 뉴스
InspireMD (NYSE:NSPR) & GBS (NYSE:GBS) Head-To-Head Comparison - Defense World
InspireMD’s (NSPR) Overweight Rating Reaffirmed at Piper Sandler - Defense World
Piper Sandler backs InspireMD stock with Overweight rating, sees FDA approval as low risk - Investing.com
NSPR Stock Declines Despite PMA Application Submission for CGuard - Yahoo Canada Finance
InspireMD (NYSE:NSPR) Given Overweight Rating at Piper Sandler - MarketBeat
NSPR Stock Declines Despite PMA Application Submission for CGuard - Zacks Investment Research
Piper Sandler backs InspireMD stock with Overweight rating, sees FDA approval as low risk - Investing.com India
Piper Sandler backs InspireMD stock with Overweight rating, sees FDA approval as low risk - Investing.com UK
InspireMD seeks FDA approval for carotid stent system - Investing.com India
InspireMD Advances Stroke Prevention with FDA PMA Submission - TipRanks
InspireMD seeks FDA approval for carotid stent system - Investing.com
InspireMD seeks FDA approval for carotid stent system By Investing.com - Investing.com UK
InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System - StockTitan
InspireMD Announces Submission of Premarket Approval - GlobeNewswire
InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard? Prime Carotid Stent System - Marketscreener.com
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - MarketBeat
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - Defense World
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - MarketBeat
InspireMD (NYSE:NSPR) Receives New Coverage from Analysts at StockNews.com - Defense World
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - MarketBeat
InspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.com - MarketBeat
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - MarketBeat
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
Earnings call: InspireMD reports growth and anticipates US launch By Investing.com - Investing.com Canada
Earnings call: InspireMD reports growth and anticipates US launch - Investing.com
Earnings call: InspireMD reports growth and anticipates US launch By Investing.com - Investing.com Australia
InspireMD, Inc. (NASDAQ:NSPR) Q2 2024 Earnings Call Transcript - Insider Monkey
InspireMD, Inc. (NSPR) Q2 2024 Earnings Call Transcript - Seeking Alpha
InspireMD, Inc. (NSPR) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update - StockTitan
InspireMD (NYSE:NSPR) Now Covered by StockNews.com - MarketBeat
NSPRInspireMD, Inc. Latest Stock News & Market Updates - StockTitan
InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment - GlobeNewswire
InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment - StockTitan
InspireMD (NSPR) Set to Announce Quarterly Earnings on Tuesday - Defense World
InspireMD (NSPR) to Release Earnings on Tuesday - MarketBeat
InspireMD to Report Second Quarter 2024 Financial Results - GlobeNewswire
InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6th - Yahoo Finance
Embolic Prevention Systems Market [Top Players ] Medtronic, Abbott, InspireMD - Economica
Head to Head Comparison: InspireMD (NYSE:NSPR) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) - Defense World
InspireMD (NYSE:NSPR) versus Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Head-To-Head Analysis - American Banking and Market News
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD Announces Distribution Agreement for CGuard(TM) EPS in Poland - Yahoo Lifestyle UK
InspireMD (NYSE:NSPR) Research Coverage Started at StockNews.com - MarketBeat
Analyzing InspireMD (NYSE:NSPR) and Monogram Orthopaedics (NASDAQ:MGRM) - Defense World
New York Stock Exchange Accepts InspireMD's Plan to Regain Compliance - Yahoo Movies UK
InspireMD announces full exercise of Series H warrant tranche - Medical Buyer
InspireMD Secures Funds to Expand Healthcare Innovations - TipRanks
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million - GlobeNewswire
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million - StockTitan
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million - Yahoo Finance
Meihua International Medical Technologies (NASDAQ:MHUA) versus InspireMD (NYSE:NSPR) Critical Contrast - Defense World
InspireMD Announces Pricing of Public Offering of Approximately $14.6 Million - Yahoo Singapore News
Neurovascular Embolic Protection Device Market with Tremendous growth by 2031 – InspireMD, Inc., Boston Scientific ... - TIMC
Quantisnow - Quantisnow
0.06%
0.40%
자본화:
|
볼륨(24시간):